COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan… - Angiogenesis, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …
syndrome coronavirus 2 (SARS-CoV-2) is presenting as a systemic disease associated with …
Persistent lung injury and prothrombotic state in long COVID
M Xiang, H Jing, C Wang, VA Novakovic… - Frontiers in …, 2022 - frontiersin.org
Lung injury may persist during the recovery period of COVID-19 as shown through imaging,
six-minute walk, and lung function tests. The pathophysiological mechanisms leading to …
six-minute walk, and lung function tests. The pathophysiological mechanisms leading to …
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase
DM Smadja, QY Yue, R Chocron… - European …, 2021 - Eur Respiratory Soc
Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic phenotype
characterised by coagulopathy and endothelial dysfunction [1–4]. Following some cases of …
characterised by coagulopathy and endothelial dysfunction [1–4]. Following some cases of …
Pathomechanisms and treatment implications for stroke in COVID-19: a review of the literature
Stroke in patients with COVID-19 has received increasing attention throughout the global
COVID-19 pandemic, perhaps due to the substantial disability and mortality that can result …
COVID-19 pandemic, perhaps due to the substantial disability and mortality that can result …
Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients
Abstract Background Coronavirus disease 2019 (COVID-19) is associated with a
hypercoagulable state. Limited data exist informing the relationship between anticoagulation …
hypercoagulable state. Limited data exist informing the relationship between anticoagulation …
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
Background It is unclear if direct-acting oral anticoagulants (DOACs) use before
hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical …
hospitalization due to COVID-19 diagnosis would potentially impact the severity and clinical …
COVID-19 and atrial fibrillation in older patients: does oral anticoagulant therapy provide a survival benefit?—an insight from the GeroCovid registry
S Fumagalli, C Trevisan, S Del Signore… - Thrombosis and …, 2022 - thieme-connect.com
Introduction Atrial fibrillation (AF), the most frequent arrhythmia of older patients, associates
with serious thromboembolic complications and high mortality. Coronavirus disease 2019 …
with serious thromboembolic complications and high mortality. Coronavirus disease 2019 …
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
Background COVID-19 is a respiratory disease that results in a prothrombotic state
manifesting as thrombotic, microthrombotic and thromboembolic events. As a result, several …
manifesting as thrombotic, microthrombotic and thromboembolic events. As a result, several …
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
M Corrochano, R Acosta-Isaac, S Mojal… - Journal of Thrombosis …, 2022 - Springer
Anticoagulant therapy is a cornerstone treatment for coronavirus disease 2019 (COVID-19)
due to the high rates of thromboembolic complications associated with this disease. We …
due to the high rates of thromboembolic complications associated with this disease. We …
Intermediate-vs. standard-dose prophylactic anticoagulation in patients with COVID-19 admitted in medical ward: a propensity score-matched cohort study
Background: Microthrombosis and large-vessel thrombosis are the main triggers of COVID-
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …
19 worsening. The optimal anticoagulant regimen in COVID-19 patients hospitalized in …